What Every Expert Should Know: Pharmacologic Approaches in Hospice and Palliative Care

With over 7 hours of learning, this recording of a full-day 2026 Annual Assembly preconference offers an in-depth, case-based exploration of complex pharmacologic strategies essential to expert-level hospice and palliative care. Building on foundational knowledge, faculty will guide participants through advanced applications of symptom management, including nuanced opioid titration, safe and effective use of adjuvant analgesics, deprescribing in multimorbidity, and pharmacologic considerations in organ dysfunction. Special attention was given to controversial and evolving areas of practice. Review interactive scenarios, expert panel discussion, and real-world clinical challenges designed to help learners refine their pharmacologic decision-making and strengthen their ability to tailor therapy for patients with complex needs.

This recording is repurposed from the 2026 Annual Assembly and does not provide CME credits.

Target Audience

Experienced clinicians

Learning Outcomes

By participating in this activity, learners will be able to:

  1. Describe the drug therapy selection process, and deprescribing process in serious illness.
  2. Given a simulated case, describe potential therapeutic options in the management of neurologic symptoms and Alzheimer’s disease.
  3. Describe best practices in the use of buprenorphine in caring for seriously ill patients.
  4. Explain the latest consensus guidance on opioid conversion calculations.
  5. Describe the outcomes of several pharmacotherapy trials involving the treatment of seriously ill patients.
Activity summary
Activity Published: 
06/22/2026
Activity Expires: 
05/31/2029
Member cost:
$300.00
List Price:
$425.00
Rating: 
0

Disclosures 
AAHPM endorses the Accreditation Council for Continuing Medical Education (ACCME) Standards for disclosure and commercial support and endeavors to ensure balance, independence, objectivity, and scientific rigor for all accredited products or programs. All who are in a position to control or influence the content of an educational activity must disclose any relevant financial relationships with ineligible companies.*Disclosure documents were reviewed for potential conflicts of interest and, if identified, were resolved prior to confirmation of participation. Only those who had no conflict of interest or who agreed to an identified resolution process prior to their participation were involved in this activity.

All editors, faculty and staff have disclosed no relevant financial relationships.

*An ineligible company is defined as any entity producing, marketing, reselling, or distributing healthcare goods or services consumed by, or used on, patients. 

Faculty
Mary Lynn McPherson, PharmD PhD FAAHPM
Eric Widera, MD
Alexandra L. McPherson, PharmD MPH
Jeremy M. Hirst, MD
Maximillian Stevenson, PharmD MA BCPS

Staff
Katie Siesel, BS
Emily Geary, BA
Krys Hansen, MS

This recorded 2026 Annual Assembly Pre-Conference session is available for informational purposes only as a non-accredited learning resource No CME or MOC is offered with this activity.

Price

Member cost:
$300.00
List Price:
$425.00
Please login or register to take this course.